| http://www.w3.org/ns/prov#value | - The development of a reliable and controlled clinical testing environment for both the PAM50 test as well as the Ki67 assay is also critical for further progress, particularly given the difficulties of methodologically reproducing data with gene expression signatures in the research setting, even when the genomic algorithm is fixed.25,26Supplementary Material
|
